Protective effect of systemic administration of erythropoietin on auditory brain stem response and compound action potential thresholds in an animal model of cochlear implantation

Annals of Otology, Rhinology and Laryngology

Volumn 120, Issue 11, 2011, Pages 737-747

  Quesnel, Stéphanie ^a,b,f   Nguyen, Yann ^a,b,f   Campo, Pierre ^g   Hermine, Olivier ^b,c,e   Ribeil, Jean Antoine ^b,c,e   Elmaleh, Monique ^d   Bozorg Grayeli, Alexis ^a,b,f   Ferrary, Evelyne ^a,b,f   Sterkers, Olivier ^a,b,f   Couloigner, Vincent ^a,b,c  

^a GH Pitié Salpêtrière Bâtiment Castaigne   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e CNRS   (France)

^f BEAUJON HOSPITAL   (France)

^g INSTITUT NATIONAL DE RECHERCHE ET DE SÉCURITÉ   (France)

Author keywords

Apoptosis; Cochlea; Guinea pig; Hearing loss; Systemic route

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY THRESHOLD; BLOOD SAMPLING; CEREBROSPINAL FLUID; COCHLEA; COCHLEOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; EXPERIMENTAL MODEL; FIBROSIS; GUINEA PIG; HEARING; HEARING LOSS; IMPLANTATION; MALE; NONHUMAN; PERILYMPH; PRESERVATION; PRIORITY JOURNAL; SYSTEMIC THERAPY;

EID: 81455128926     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941112001108     Document Type: Article

References (30)

1. James CJ, Fraysse B, Deguine O, et al. Combined electroacoustic stimulation in conventional candidates for cochlear implantation. Audiol Neurootol 2006;11(suppl 1):57-62. (Pubitemid 44629844)
2. Gantz BJ, Turner C, Gfeller KE, Lowder MW. Preservation of hearing in cochlear implant surgery: advantages of combined electrical and acoustical speech processing. Laryngoscope 2005;115:796-802. (Pubitemid 40604682)
3. Lehnhardt E. Intracochlear placement of cochlear implant electrodes in soft surgery technique [in German]. HNO 1993;41:356-9.
4. Talbot KN, Hartley DE. Combined electro-acoustic stimulation: a beneficial union? Clin Otolaryngol 2008;33:536-45.
5. Lenarz T, Stover T, Buechner A, et al. Temporal bone results and hearing preservation with a new straight electrode. Audiol Neurootol 2006;11(suppl 1):34-41. (Pubitemid 44629841)
6. Scarpidis U, Madnani D, Shoemaker C, et al. Arrest of apoptosis in auditory neurons: implications for sensorineural preservation in cochlear implantation. Otol Neurotol 2003;24: 409-17. (Pubitemid 36618163)
7. Eshraghi AA, Polak M, He J, Telischi FF, Balkany TJ, Van De Water TR. Pattern of hearing loss in a rat model of cochlear implantation trauma. Otol Neurotol 2005;26:442-7. (Pubitemid 40663872)
8. Malgrange B, Rigo JM, Coucke P, et al. Identification of factors that maintain mammalian outer hair cells in adult organ of Corti explants. Hear Res 2002;170:48-58.
9. Eshraghi AA, He J, Mou CH, et al. D-JNKI-1 treatment prevents the progression of hearing loss in a model of cochlear implantation trauma. Otol Neurotol 2006;27:504-11.
10. Couloigner V, Bozorg Grayeli A, Bouccara D, Sterkers O, Ferrary E. Antioxidants and inner ear protection. J Fr ORL 2001;50:314-8.
11. Maiese K, Chong ZZ, Li F, Shang YC. Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. Prog Neurobiol 2008;85:194-213.
12. Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 2000;97:10526-31.
13. Sirén AL, Ehrenreich H. Erythropoietin - a novel concept for neuroprotection. Eur Arch Psychiatry Clin Neurosci 2001;251:179-84. (Pubitemid 32963495)
14. Grimm C, Wenzel A, Groszer M, et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002;8:718-24. (Pubitemid 34778725)
15. Cayé-Thomasen P, Wagner N, Lidegaard Frederiksen B, Asal K, Thomsen J. Erythropoietin and erythropoietin receptor expression in the guinea pig inner ear. Hear Res 2005;203:21-7. (Pubitemid 40602812)
16. Andreeva N, Nyamaa A, Haupt H, Gross J, Mazurek B. Recombinant human erythropoietin prevents ischemia-induced apoptosis and necrosis in explant cultures of the rat organ of Corti. Neurosci Lett 2006;396:86-90. (Pubitemid 43276418)
17. Greenwood DD. A cochlear frequency-position function for several species - 29 years later. J Acoust Soc Am 1990;87:2592-605. (Pubitemid 20289735)
18. Sterkers O, Saumon G, Tran Ba Huy P, Amiel C. K, Cl, and H2O entry in endolymph, perilymph, and cerebrospinal fluid of the rat. Am J Physiol 1982;243:F173-F180. (Pubitemid 12050117)
19. Eshraghi AA, Adil E, He J, Graves R, Balkany TJ, Van de Water TR. Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol 2007;28:842-9. (Pubitemid 47329902)
20. James DP, Eastwood H, Richardson RT, O'Leary SJ. Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation. Audiol Neurootol 2008;13:86-96. (Pubitemid 351225887)
21. Chang A, Eastwood H, Sly D, James D, Richardson R, O'Leary S. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res 2009;255:67-72.
22. Nguyen Y, Couloigner V, Rudic M, Bozorg Grayeli A, Ferrary E, Sterkers O. An animal model of cochlear implantation with an intracochlear fluid delivery system. Acta Otolaryngol 2009;129:1153-9.
23. Eastwood H, Pinder D, James D, et al. Permanent and transient effects of locally delivered n-acetyl cysteine in a guinea pig model of cochlear implantation. Hear Res 2010;259:24-30.
24. Thorne M, Salt AN, DeMott JE, Henson MM, Henson OW Jr, Gewalt SL. Cochlear fluid space dimensions for six species derived from reconstructions of three-dimensional magnetic resonance images. Laryngoscope 1999;109:1661-8. (Pubitemid 29477235)
25. Kobayashi T, Gyo K, Yanagihara N. Combined rupture of Reissner's membrane and round window: an experimental study in guinea pigs: experimental double-membrane rupture. Am J Otol 1999;20:179-82. (Pubitemid 29476643)
26. Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem 2001;276:39469-75.
27. Villa P, Bigini P, Mennini T, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003; 198:971-5. (Pubitemid 37152934)
28. Chattopadhyay A, Choudhury TD, Bandyopadhyay D, Datta AG. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol 2000;59:419-25. (Pubitemid 30015971)
29. Statler PA, McPherson RJ, Bauer LA, Kellert BA, Juul SE. Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res 2007;61:671-5. (Pubitemid 46800274)
30. Plontke SK, Siedow N, Wegener R, Zenner HP, Salt AN. Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model. Audiol Neurootol 2007;12:37-48. (Pubitemid 44967985)